Dr. Reddy’s Warns US Market ‘Unpredictable’ As Q4 Profit Below Expectations

Dr. Reddy’s Laboratories, India’s second-largest drug firm by sales, has warned that its key US export market remains “unpredictable” after reporting a lower than expected fourth-quarter net profit that capped a tough year.